Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000488157 | SCV000575459 | uncertain significance | not provided | 2016-09-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000488157 | SCV001815236 | uncertain significance | not provided | 2024-05-21 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Ambry Genetics | RCV002413345 | SCV002675479 | benign | Cardiovascular phenotype | 2020-04-17 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002481544 | SCV002793628 | uncertain significance | Ehlers-Danlos syndrome due to tenascin-X deficiency; Vesicoureteral reflux 8 | 2021-12-14 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000488157 | SCV005412082 | uncertain significance | not provided | 2024-08-09 | criteria provided, single submitter | clinical testing |